Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7050
+0.0550 (3.33%)
NASDAQ · Last Trade: Jan 16th, 2:24 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors